Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins

Clinical Rheumatology

Volumn 18, Issue 1, 1999, Pages 77-81

  Arahata, H ^a   Migita, K ^a   Izumoto, H ^a   Miyashita, T ^a   Munakata, H ^a   Nakamura, H ^a   Tominaga, M ^a   Origuchi, T ^a   Kawabe, Y ^a   Hida, A ^a   Taguchi, T ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti neutrophil cytoplasmic antibody; High dose intravenous immunoglobulin; Lupus nephritis; Rapidly progressive glomerulonephritis

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DRUG MEGADOSE; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, ACUTE; KIDNEY GLOMERULUS; LUPUS NEPHRITIS;

EID: 0033005725     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050060     Document Type: Article

References (24)

1. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenic mechanisms, and therapy. Am J Kidney Dis 1988;11:449-64.
2. Leib BS, Restivo C, Paulus HE. Immunosuppressive therapy and corticosteroid therapy of polyarteritis nodosa. Am J Med 1979;67:941-7.
3. Andrassy K, Kosten S, Waldherr R. Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. Nephron 1991;59:206-12.
4. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
5. Jennette JC, Wilkman AS, FaIk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989;135:921-30.
6. Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, et al. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990;37:799-806.
7. Kuster S, Apenberg S, Andrassy K, Ritz E. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Contrib Nephrol 1992;99:94-7.
8. Camdbridge G, Wallace H, Bernstein RM, Leaker B. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994;33:109-14.
9. Pirani CL, O'Lesnicky L. Role of electron microscopy in the classification of lupus nephritis. Am J Kidney Dis 1982;2:150-63.
10. Austin HA, Muenz LR, Joyce KM, Antonvych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25:689-95.
11. Schwarz, MM, Roberts JL, Lewis EJ. Necrotizing glomerulitis of lupus erythematosus. Hum Pathol 1983;4:158-67.
12. Akhtar M, Abdullah Al-Dalaan A, El-Ramihi KM. Pauci-immune necrotizing lupus nephritis: report of two cases. Am J Kidney Dis 1994;23:320-5.
13. Marshall S, Dressier R, D'Agati V. Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 1997;29:199-204.
14. Kallenberg CGM, Brouwer E, Weening JJ, Tervaert JWC. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994;46:1-15.
15. Hughson D, Nasasdy T, McCarty GA, Shaler CMin KW, Silvia F. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and antiphospholipid syndrome. Am J Kidney Dis 1992;20:150-8.
16. Amigo MC, Garcia-Torres R, Roffes M, Bochicchio T, Reyes PA. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992;19:1181-5.
17. Austin HA III, Kippel JH, Balow JE, le Riche NGH, Steinberg AD, Plotz PH, Decker JH. Therapy of lupus nephritis: controlled trial of prednisolone and cytotoxic drugs. N Engl J Med 1986;314:614-9.
18. Falk JR, Hogan S, Carey TS, Jennette JC. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990;113:656-63.
19. Jordan SC. Intravenous γ-globulin therapy in systemic lupus erythematosus and immune complex disease. Clin Immunol Immunopathol 1989;53:164-9.
20. Palla R, Cirami C, Bionda A, Marchitiello M. High-dose intravenous gamma-globulin for membranous nephropathy. Clin Exp Immunol 1986;26:314-9.
21. Jayne DRW, Davies MJ, Fox CJV, Black CM, Lockwood CM. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991;337:1137-9.
22. Rossi F, Jayne DRW, Lockwood CM, Kazachkine MD. Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and the remission sera of patient with systemic vasculitis. Clin Exp Immunol 1991;83:298-303.
23. Schifferli J, Leski M, Favre H, Imbach P, Nydegger U, Davies K. High-dose intravenous IgG treatment and renal function. Lancet 1991;337:457-8.
24. Reinhart WH, Berchtold PE. Effect of high-dose immunoglobulin therapy on blood rheology. Lancet 1992;399:662-4.